Veradermics declares first efficacy win in women for hair loss drug

Phase 2positiveoral minoxidilPositive

AI Analysis

Summary

Veradermics reported positive efficacy data for its oral minoxidil formulation in female pattern hair loss during a mid-stage trial, expanding the market potential of this flagship asset to the female population.

Clinical Trial Data

Phase

Primary Endpoint

Met

Outcome Details

First efficacy win in women for oral minoxidil in female pattern hair loss

Importance:6/10

Sentiment:

0.70

dermatologyhair losswomen's healthoral formulationefficacy

Related Companies

$TRAX

Read the original article

Published by Endpoints News on July 15, 2026 11:04 AM

Read Original